Login

Get to know Erica Yount of Modera Wealth Management, LLC 00:10:00

Share On Facebook Share On Twitter

Tom Orecchio, CFA, CFP - Chief Executive Officer - Modera Wealth Management

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Image Resources: Advancing Mineral Sands Projects from Exploration to Production
00:10:00
Exploring Opportunities in Alternative Asset Classes
00:10:00
The Power of Being a Generalist: Insights from David Epstein | Podcast Episode on In Good Company by Norges Bank Investment Management
00:10:00
Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck
00:10:00
The 'secret' Creandum tech-exit database|Staffan Helgesson,General Partner,Creandum
00:10:00
Daniel Lee and Peter Lazaroff on Optimizing Retirement and Investment Strategies | Peter Lazaroff, CIO, Plancorp LLC.
00:10:00
The GO Foundation South Australia launches on Friday, February 15, at the Adelaide Fringe Festival along the Torrens River.
00:10:00
Special Market Briefing: Growth Companies in Euronext Growth Segment of Borsa Italiana | Nicola Voltan, CEO, Siav Spa.
00:10:00
Insights into Germany's Economic Landscape and Mid Cap Potential | Gerhard Orgonas, Head of equity research ,  Berenberg Bank .
00:10:00
Eritrea's Mining Potential: A Conversation with Theo Batulis of Anyama Exploration
00:10:00
Liberty Gold: Focused on Great Basin Sediment-Hosted Oxide Gold Systems
00:00:00
Fred Marshall Winston, Ph.D. John Emory Andrus Professor of Genetics, HMS | The Ins and Outs of Gene Regulation

© 2026 Nehu